首页> 外文期刊>Архив патологии >Comparative immunohistochemical study of invasive duct carcinoma and Paget's disease of the breast with c-erbB-2 overexpression
【24h】

Comparative immunohistochemical study of invasive duct carcinoma and Paget's disease of the breast with c-erbB-2 overexpression

机译:c-erbB-2过表达对乳腺浸润性导管癌和Paget病的免疫组织化学比较研究

获取原文
获取原文并翻译 | 示例
           

摘要

Overexpression of c-erbB2 oncogen is observed in 90-100% of cases of Paget's cancer. In all cases, the overexpression is caused by gene amplification. The authors carried out an immun ohistochemrical study of c-erbB2 (HER2eu)-positive breast tumors: Paget's cancer (and hence with gene amplification) and breast invasive duct cancer without gene amplification. Moreover, the authors identified a case of c-erbB2-negative Paget's cancer, the phenotype of which was compared with the phenotypes of two earlier groups of tumors. The findings suggest that only formation of c-erbB2 heterodimers that cannot cause an increase in proliferation on their own is observed in the study groups of tumors.
机译:在Paget's癌症的90-100%的病例中观察到c-erbB2癌基因的过度表达。在所有情况下,过表达都是由基因扩增引起的。作者对c-erbB2(HER2 / neu)阳性乳腺肿瘤进行了免疫组织化学研究:Paget癌(并因此有基因扩增)和无基因扩增的乳腺浸润性导管癌。此外,作者鉴定出一例c-erbB2阴性Paget癌,将其表型与早期两组肿瘤的表型进行比较。这些发现表明,在肿瘤研究组中仅观察到了不能单独引起增殖增加的c-erbB2异二聚体的形成。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号